Advertisement.

VIAP Projected Dividend Yield

VIA Pharmaceuticals Inc ( OTCBB : VIAP )

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the treatment of cardiovascular and metabolic diseases. Co. is building a pipeline of small-molecule drugs that target cardiovascular and metabolic diseases. As of Dec 31 2010, Co.'s drug development pipeline included: VIA-3196, a liver-directed thyroid hormone receptor beta agonist, including high LDL cholesterol, high triglycerides and elevated Lp(a); a Diacylglycerol Acyl Transferase 1 inhibitor for diabetes, with upside potential in weight control and dyslipidemia; and its 5-LO inhibitor, VIA-2291, which targets the treatment of atherosclerotic plaque, a primary cause of heart attack, stroke and other vascular diseases.

20 YEAR PERFORMANCE RESULTS

VIAP Dividend History Detail
VIAP Dividend News
VIAP Competitors News

# of Shares: 0

Closing Price: 0.00

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000